Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | -0.33% | -4.76% | -6.83% |
May. 14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
May. 14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 2.07M | Sales 2025 * | 54.11M | Capitalization | 214M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -22M | EV / Sales 2024 * | 103 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.95 x |
P/E ratio 2024 * |
-3.5
x | P/E ratio 2025 * |
-10.6
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.13% |
Latest transcript on Ovid Therapeutics Inc.
1 day | -6.81% | ||
1 week | -8.09% | ||
Current month | -1.31% | ||
1 month | -5.94% | ||
3 months | -18.65% | ||
6 months | -9.88% | ||
Current year | -6.52% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 18-12-31 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 17-06-13 |
Bart Friedman
BRD | Director/Board Member | 79 | 15-11-22 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 3 | -0.33% | 113 605 |
24-05-23 | 3.01 | -6.81% | 133,120 |
24-05-22 | 3.23 | +3.86% | 117,264 |
24-05-21 | 3.11 | -0.96% | 41,552 |
24-05-20 | 3.14 | -0.32% | 65,919 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.52% | 214M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.52% | 21.58B | |
-11.32% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- OVID Stock